Literature DB >> 12239317

Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Woei Ling Peh1, Kate Middleton, Neil Christensen, Philip Nicholls, Kiyofumi Egawa, Karl Sotlar, Janet Brandsma, Alan Percival, Jon Lewis, Wen Jun Liu, John Doorbar.   

Abstract

Animal papillomaviruses are widely used as models to study papillomavirus infection in humans despite differences in genome organization and tissue tropism. Here, we have investigated the extent to which animal models of papillomavirus infection resemble human disease by comparing the life cycles of 10 different papillomavirus types. Three phases in the life cycles of all viruses were apparent using antibodies that distinguish between early events, the onset of viral genome amplification, and the expression of capsid proteins. The initiation of these phases follows a highly ordered pattern that appears important for the production of virus particles. The viruses examined included canine oral papillomavirus, rabbit oral papillomavirus (ROPV), cottontail rabbit papillomavirus (CRPV), bovine papillomavirus type 1, and human papillomavirus types 1, 2, 11, and 16. Each papillomavirus type showed a distinctive gene expression pattern that could be explained in part by differences in tissue tropism, transmission route, and persistence. As the timing of life cycle events affects the accessibility of viral antigens to the immune system, the ideal model system should resemble human mucosal infection if vaccine design is to be effective. Of the model systems examined here, only ROPV had a tissue tropism and a life cycle organization that resembled those of the human mucosal types. ROPV appears most appropriate for studies of the life cycles of mucosal papillomavirus types and for the development of prophylactic vaccines. The persistence of abortive infections caused by CRPV offers advantages for the development of therapeutic vaccines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239317      PMCID: PMC136551          DOI: 10.1128/jvi.76.20.10401-10416.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  94 in total

1.  Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1.

Authors:  D J Klumpp; L A Laimins
Journal:  Virology       Date:  1999-04-25       Impact factor: 3.616

2.  Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10.

Authors:  M N Ruesch; F Stubenrauch; L A Laimins
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia.

Authors:  N J Maitland; S Conway; N S Wilkinson; J Ramsdale; J R Morris; C M Sanders; J E Burns; P L Stern; M Wells
Journal:  J Pathol       Date:  1998-11       Impact factor: 7.996

4.  Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4.

Authors:  J Doorbar; C Foo; N Coleman; L Medcalf; O Hartley; T Prospero; S Napthine; J Sterling; G Winter; H Griffin
Journal:  Virology       Date:  1997-11-10       Impact factor: 3.616

5.  Laboratory production in vivo of infectious human papillomavirus type 11.

Authors:  J W Kreider; M K Howett; A E Leure-Dupree; R J Zaino; J A Weber
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

6.  Identification of conserved hydrophobic C-terminal residues of the human papillomavirus type 1 E1E4 protein necessary for E4 oligomerisation in vivo.

Authors:  I Ashmole; P H Gallimore; S Roberts
Journal:  Virology       Date:  1998-01-20       Impact factor: 3.616

7.  The intracellular expression pattern of the human papillomavirus type 11 E1--E4 protein correlates with its ability to self associate.

Authors:  J T Bryan; K H Fife; D R Brown
Journal:  Virology       Date:  1998-02-01       Impact factor: 3.616

8.  Natural history of cervicovaginal papillomavirus infection in young women.

Authors:  G Y Ho; R Bierman; L Beardsley; C J Chang; R D Burk
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

Review 9.  Control of papillomavirus DNA replication and transcription.

Authors:  C Desaintes; C Demeret
Journal:  Semin Cancer Biol       Date:  1996-12       Impact factor: 15.707

10.  Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates.

Authors:  M G Frattini; H B Lim; J Doorbar; L A Laimins
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

View more
  77 in total

1.  Novel betapapillomavirus associated with hand and foot papillomas in a cynomolgus macaque.

Authors:  C E Wood; S H Tannehill-Gregg; Z Chen; K van Doorslaer; D R Nelson; J M Cline; R D Burk
Journal:  Vet Pathol       Date:  2010-10-04       Impact factor: 2.221

2.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Authors:  Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

3.  The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

Authors:  Sigrid C Holmgren; Nicole A Patterson; Michelle A Ozbun; Paul F Lambert
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31.

Authors:  Regina Wilson; Frauke Fehrmann; Laimonis A Laimins
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.

Authors:  Alexandra Côté-Martin; Cary Moody; Amélie Fradet-Turcotte; Claudia M D'Abramo; Michaël Lehoux; Simon Joubert; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 6.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

7.  Structural analysis reveals an amyloid form of the human papillomavirus type 16 E1--E4 protein and provides a molecular basis for its accumulation.

Authors:  Pauline B McIntosh; Stephen R Martin; Deborah J Jackson; Jameela Khan; Erin R Isaacson; Lesley Calder; Kenneth Raj; Heather M Griffin; Qian Wang; Peter Laskey; John F Eccleston; John Doorbar
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Xist deficiency and disorders of X-inactivation in rabbit embryonic stem cells can be rescued by transcription-factor-mediated conversion.

Authors:  Yonghua Jiang; Zhaohui Kou; Tong Wu; Weidong An; Ran Zhou; Hong Wang; Yawei Gao; Shaorong Gao
Journal:  Stem Cells Dev       Date:  2014-06-26       Impact factor: 3.272

9.  Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability.

Authors:  Qian Wang; Alan Kennedy; Papia Das; Pauline B McIntosh; Steven A Howell; Erin R Isaacson; Steven A Hinz; Clare Davy; John Doorbar
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

10.  E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population.

Authors:  Wen-Jing Shi; Hao Liu; Dan Wu; Zhen-Hua Tang; Yu-Chen Shen; Lin Guo
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.